Moreover, this increase in SCD1 expression is positively correlated with cancer aggressiveness and poor patient prognosis in liver, thyroid, prostate, pancreatic, kidney, skin, and breast cancer [16,26,27,28,29]. This evidence concerns the gene SCD and breast cancer.